Table 4.
Adverse event | No. patients (%) n = 61 |
---|---|
All adverse events | |
Somnolence | 48 (79%) |
Constipation | 35 (57%) |
Dry mouth | 34 (56%) |
Peripheral neuropathy | 34 (56%) |
Skin rash | 33 (54%) |
Fever | 20 (33%) |
Neutropenia | 15 (25%) |
Finger tremor | 14 (23%) |
Infection | 12 (20%) |
Dizziness | 11 (18%) |
Thrombocytopenia | 10 (16%) |
Fatigue | 9 (15%) |
Gastrointestinal symptoms | 6 (10%) |
Headache | 6 (10%) |
Grade ≥ 3 adverse events only | |
Neutropenia | 13 (22%) |
Infection | 11 (18%) |
Thrombocytopenia | 7 (11%) |
Lymphopenia | 3 (5%) |
Peripheral neuropathy | 1 (2%) |
Dizziness | 1 (2%) |
Gastrointestinal symptoms | 1 (2%) |
Interstitial pneumonia | 1 (2%) |
Pulmonary hypertension | 1 (2%) |
Hearing disturbance | 1 (2%) |
Wrist‐drop | 1 (2%) |